Physician

Steve F Springer, MD

According to 2025 Medicare claims, Steve Springer, MD (NPI: 1477538619) practices family practice in the Lake Charles, LA market, with the plurality of this provider's patient population coming from Calcasieu, LA. This provider's primary affiliated billing organization is IMPERIAL HEALTH, LLP (NPI: 1053352401; TIN: 721005645) and primary practice location at 70601-5726. Springer is affiliated with the Aledade 35 Lagniappe MSSP Enhanced (ACO ID: A3899), participating under the MSSP model.

Springer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 668 traditional Medicare patients, billed 11,730 HCPCS/CPT codes, and received $453,333 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 15,200 prescription claims across 1,031 beneficiaries totaling $1,421,752 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 75 claims. Open Payments data shows 43 records totaling $849. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $175,984 to $453,333. Similarly, Part D prescription costs have moved sharply higher in recent years, from $623,063 to $1,421,752. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $78,165 to $18,278.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	441	5,422	$175,984
2016	480	5,396	$209,170
2017	471	5,504	$208,098
2018	441	6,678	$234,816
2019	414	6,960	$241,119
2020	411	8,089	$296,987
2021	436	8,054	$299,556
2022	371	8,693	$329,610
2023	332	9,216	$365,825
2024	668	11,730	$453,333

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	369	7,295	$623,063
2016	407	7,988	$604,237
2017	412	8,728	$663,090
2018	426	8,741	$672,863
2019	470	8,829	$738,126
2020	515	9,004	$774,917
2021	612	10,026	$762,719
2022	615	11,725	$1,018,058
2023	604	12,553	$1,275,877
2024	1,031	15,200	$1,421,752

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	233	743	$72,471
2016	226	706	$32,656
2017	187	624	$29,118
2018	152	559	$20,669
2019	119	668	$39,544
2020	85	282	$10,682
2021	69	213	$9,482
2022	38	230	$13,540
2023	22	178	$11,643
2024	N/R	75	$11,843

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	244	244	$120
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	559	1,718	$87
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	407	2,178	$45
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	409	780	$12
36415	Insertion of needle into vein for collection of blood sample	254	333	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	270	8,604	$315,056
Farxiga	Dapagliflozin Propanediol	199	9,190	$165,693
Ozempic	Semaglutide	104	4,788	$147,909
Jardiance	Empagliflozin	145	7,015	$135,022
Eliquis	Apixaban	104	4,632	$80,579

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	27	$10,884
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	19	$500
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	17	$328
A7038	Filter, disposable, used with positive airway pressure device	N	N/R	12	$131

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	43	$849	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Steve F. Springer, MD?

Tedicare shows public-source Medicare data for Steve F. Springer, MD (NPI 1477538619), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Steve F. Springer, MD have ACO affiliation data?

Steve F. Springer, MD is shown with ACO affiliation data for Aledade 35 Lagniappe MSSP Enhanced (MSSP, ACO ID A3899).

What billing organization is linked to Steve F. Springer, MD?

Steve F. Springer, MD is linked to IMPERIAL HEALTH, LLP (billing NPI 1053352401) in the available physician profile data.

Does Steve F. Springer, MD have Open Payments data?

Steve F. Springer, MD has 43 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.